论文部分内容阅读
目的探讨尼莫地平在蛛网膜下腔出血患者治疗中的应用价值。方法 76例蛛网膜下腔出血患者,随机分成观察组与对照组,各38例。对照组患者实施常规治疗,观察组患者在对照组基础上加用尼莫地平治疗,对比两组患者的临床治疗总有效率、脑血管痉挛发生率以及死亡率。结果经过对比,观察组患者的临床治疗总有效率为92.11%(35/38)高于对照组的76.32%(29/38),差异有统计学意义(χ2=9.6341,P<0.05);观察组患者的脑血管痉挛发生率及死亡率显著低于对照组,差异有统计学意义(χ2=9.1542、10.6347,P<0.05)。结论在蛛网膜下腔出血患者临床治疗中加用尼莫地平,能够显著提高患者的临床治疗有效性,同时降低患者脑血管痉挛发生率和死亡率,值得推广应用。
Objective To investigate the clinical value of nimodipine in the treatment of patients with subarachnoid hemorrhage. Methods 76 cases of subarachnoid hemorrhage were randomly divided into observation group and control group, 38 cases in each. Patients in the control group were treated with conventional therapy. Patients in the observation group were treated with nimodipine on the basis of the control group. The total effective rate of treatment, the incidence of cerebral vasospasm and mortality in both groups were compared. Results After the comparison, the total effective rate of clinical observation in the observation group was 92.11% (35/38), which was significantly higher than that in the control group (76.32%, 29/38) (χ2 = 9.6341, P <0.05) Group of patients with cerebral vasospasm and mortality was significantly lower than the control group, the difference was statistically significant (χ2 = 9.1542,10.6347, P <0.05). Conclusion The clinical application of nimodipine in patients with subarachnoid hemorrhage can significantly improve the effectiveness of clinical treatment, and reduce the incidence of cerebral vasospasm and mortality in patients, it is worth promoting the application.